Actinium Pharmaceuticals, Inc. To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention In San Diego On June 26th

Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Dr. Kaushik J. Dave, President and CEO of Actinium, will present a corporate update at the 2014 BIO International Convention in San Diego, CA on June 26th, 2014.

Help employers find you! Check out all the jobs and post your resume.